Owlet (OWLT) Income from Continuing Operations (2020 - 2026)
Owlet's (OWLT) quarterly Income from Continuing Operations came in at 3336000.0 in Q1 2026, down 210.28% year-on-year from 3025000.0 in Q1 2025, and up 63.7% on a QoQ basis from 9190000.0 in Q4 2025.
Owlet (OWLT) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Income from Continuing Operations data on file, last reported at 3336000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 210.28% year-over-year to 3336000.0 in Q1 2026; TTM through Mar 2026 was 46039000.0, a 260.1% decrease from a year earlier, with the FY2025 full-year figure at 39678000.0, down 216.51% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 3336000.0, up from 9190000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for OWLT reached as high as 4134000.0 in Q3 2025 and fell as low as 37647000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 9869823.53 across 5 years, with a median of 8467000.0 in 2023.
- On a YoY basis, Income from Continuing Operations climbed as much as 173.68% in 2025 and fell as far as 3182.21% in 2025.
- Year by year, Income from Continuing Operations stood at 19498000.0 in 2022, then surged by 64.48% to 6926000.0 in 2023, then sank by 30.7% to 9052000.0 in 2024, then fell by 1.52% to 9190000.0 in 2025, then soared by 63.7% to 3336000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 3336000.0 in Q1 2026, 9190000.0 in Q4 2025, and 4134000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Owlet | 147.80 Mn | 106.79 Mn | 12.24 Mn | -3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.34 Mn |
| Dec 31, 2025 | -9.19 Mn |
| Sep 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | -37.65 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | -9.05 Mn |
| Sep 30, 2024 | -5.61 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | -6.93 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -8.47 Mn |
| Mar 31, 2023 | -11.87 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -19.36 Mn |
| Jun 30, 2022 | -11.72 Mn |
| Mar 31, 2022 | -28.76 Mn |
| Dec 31, 2021 | -24.06 Mn |
| Sep 30, 2021 | -34.46 Mn |
| Jun 30, 2021 | -5.34 Mn |